tuberculosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Inhalation of Mycobacterium tuberculosis leads to alveolar macrophage phagocytosis, but the bacteria resist destruction by inhibiting phagosome-lysosome fusion, allowing intracellular survival and proliferation.

• Secondary mechanism: The immune response, characterized by delayed-type hypersensitivity, forms granulomas to contain the infection. Central caseation necrosis can develop, potentially leading to tissue damage and cavitation within the lungs.

• Key complication: Dissemination of bacteria via the bloodstream can result in extrapulmonary tuberculosis, affecting organs such as the kidneys, spine, or brain, leading to severe complications like renal failure, Pott's disease, or tuberculous meningitis.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Previously treated for latent tuberculosis, history of type 2 diabetes mellitus, chronic obstructive pulmonary disease (COPD), and hypertension

• Current medications: Metformin, Lisinopril, Albuterol inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and severe shortness of breath

• Key symptoms: Night sweats, significant weight loss, fever, hemoptysis, chest pain, fatigue

• Vital signs: Temperature: 102.4°F (39.1°C), Heart rate: 126 bpm, Respiratory rate: 32 breaths/min, Blood pressure: 88/54 mmHg, Oxygen saturation: 85% on room air

Section 1

As the clinical team conducts an initial assessment, the severity of the patient's condition becomes increasingly apparent. A thorough respiratory examination reveals diminished breath sounds bilaterally, with crackles and wheezing more prominent in the upper lobes. The cough is accompanied by rust-colored sputum, indicative of ongoing hemoptysis. The patient appears in acute distress, with accessory muscle use and nasal flaring noted, highlighting the effort required to breathe. A focused cardiovascular assessment shows jugular venous distention and peripheral edema, suggesting potential right-sided heart strain secondary to pulmonary complications. The patient's skin is diaphoretic and warm to the touch, correlating with the febrile state.

Laboratory tests return alarming findings. The complete blood count indicates leukocytosis with a left shift, reflecting a heightened inflammatory response. An arterial blood gas analysis shows a significant respiratory acidosis with partial metabolic compensation (pH 7.28, PaCO2 58 mmHg, HCO3- 28 mEq/L), underscoring the severity of the respiratory compromise and the body's attempt to counteract it. Chest X-ray and CT imaging reveal extensive bilateral infiltrates with cavitation, consistent with active pulmonary tuberculosis, and concerning opacities suggest possible miliary spread. Sputum samples are positive for acid-fast bacilli, confirming active Mycobacterium tuberculosis infection, and further culture and sensitivity tests are pending to guide targeted antimicrobial therapy.

The patient's condition necessitates urgent intervention. The healthcare team initiates high-flow oxygen therapy to improve oxygen saturation and begins a four-drug antitubercular regimen, carefully considering the patient's penicillin allergy. Despite these measures, the patient's blood pressure remains low, prompting the initiation of intravenous fluids and vasopressors to stabilize hemodynamics. Given the risk of acute respiratory failure, the team discusses the possibility of mechanical ventilation should the patient's respiratory status continue to deteriorate. The complex interplay of the patient's comorbid conditions, including diabetes and COPD, requires meticulous monitoring and adjustment of therapeutic strategies, highlighting the need for advanced clinical judgment as the team navigates this critical juncture in the patient's care journey.

Section 2

As the clinical team continues to monitor the patient closely, a notable change in the patient's status becomes evident. Despite high-flow oxygen therapy, the patient's oxygen saturation begins to decline, dropping to 85% on 60% FiO2, indicating worsening respiratory distress. The patient exhibits increased tachypnea, with a respiratory rate climbing to 35 breaths per minute, and a heart rate that has increased to 130 beats per minute. The patient's blood pressure remains labile, with systolic readings fluctuating between 85-95 mmHg, despite vasopressor support. This hemodynamic instability raises concerns about impending respiratory failure and shock.

Concurrently, new diagnostic results further complicate the clinical picture. Repeat arterial blood gas analysis reveals a worsening respiratory acidosis (pH 7.24, PaCO2 62 mmHg, HCO3- 30 mEq/L), indicating that the patient's respiratory system is struggling to maintain homeostasis. The lactate level is elevated at 4.2 mmol/L, suggesting tissue hypoperfusion and possible sepsis, likely secondary to disseminated tuberculosis. A repeat chest CT scan shows progressive bilateral infiltrates with increased cavitation and new pleural effusions, complicating the respiratory status and possibly indicating a superimposed bacterial infection.

In response to these changes, the team intensifies the therapeutic approach. Mechanical ventilation is initiated to relieve the work of breathing and improve gas exchange, as the patient is prepped for intubation. Broad-spectrum antibiotics are added to the treatment regimen, pending blood culture results to address the possible secondary infection. Continuous hemodynamic monitoring is established in the ICU, and fluid management is adjusted to optimize perfusion while avoiding fluid overload given the risk of right-sided heart failure. The complexity of these interventions necessitates vigilant reassessment and adaptation, as the team strives to stabilize the patient amidst the evolving clinical challenges.

Section 3

New complications arise as the patient’s condition continues to deteriorate, demanding rapid and precise clinical intervention. Despite mechanical ventilation, the patient's oxygenation remains compromised, with SpO2 levels persistently hovering around 88% even on a high PEEP setting. The ventilator settings are adjusted for optimal alveolar recruitment, yet the patient exhibits signs of barotrauma, evidenced by crepitus upon palpation of the chest, suggestive of subcutaneous emphysema. This raises immediate concern for a possible pneumothorax, necessitating an urgent bedside ultrasound to confirm the diagnosis.

Meanwhile, the patient's renal function shows alarming signs of decline. Serum creatinine levels have doubled over the past 24 hours, now at 3.4 mg/dL, reflecting acute kidney injury likely secondary to the combination of sepsis and nephrotoxic drug effects. The patient's urine output has decreased significantly, with less than 0.3 mL/kg/hr, indicating oliguria. This renal compromise complicates fluid management strategies, as the team must balance the need for adequate perfusion with the risk of exacerbating pulmonary edema.

In parallel, the patient's coagulation profile reveals new-onset thrombocytopenia, with platelet counts dropping to 70,000/µL. This finding, along with elevated D-dimer levels, raises suspicion for disseminated intravascular coagulation (DIC), further complicating the clinical picture. As the team reviews these findings, they must quickly adjust the therapeutic plan to incorporate renal replacement therapy options and potential interventions for DIC, all while maintaining a focus on stabilizing the patient's respiratory status. These new complications demand a multidisciplinary approach and precise clinical reasoning to navigate the intricate interplay of respiratory, renal, and hematologic challenges.

Section 4

As the critical care team urgently addresses the potential pneumothorax, the bedside ultrasound reveals a right-sided pneumothorax with a 20% collapse of the lung. A chest tube is promptly inserted to relieve the pressure, which initially stabilizes the patient's condition. However, the procedure exacerbates the patient's respiratory distress, and despite the intervention, the SpO2 levels fluctuate between 85-89%, indicating persistent hypoxemia. The team decides to initiate high-frequency oscillatory ventilation (HFOV) to improve oxygenation while minimizing further barotrauma risk. Despite these efforts, the patient's arterial blood gas shows a pH of 7.28, PaCO2 of 58 mmHg, and PaO2 of 52 mmHg, suggesting worsening respiratory acidosis.

Concurrently, the nephrology team evaluates the renal profile and considers initiating continuous renal replacement therapy (CRRT) to manage the acute kidney injury and fluid overload. The patient's blood pressure has dropped to 88/54 mmHg, with a heart rate of 112 bpm, indicating potential hemodynamic instability. The team carefully initiates CRRT, selecting a slow continuous ultrafiltration (SCUF) mode to avoid rapid shifts in volume status. As the procedure begins, the patient’s urine output remains scant, further supporting the need for renal support.

The hematology team, meanwhile, is consulted regarding the suspected disseminated intravascular coagulation (DIC). An emergent coagulation panel shows an INR of 2.1 and fibrinogen levels of 150 mg/dL, confirming DIC. The team initiates a transfusion of platelets and fresh frozen plasma to manage the coagulopathy. As these interventions unfold, the patient's clinical status continues to demand close observation and rapid adjustments in treatment strategy, highlighting the need for seamless coordination among the multidisciplinary team. The complex interplay of respiratory, renal, and hematologic challenges requires ongoing critical evaluation and adaptation of the treatment plan to stabilize the patient's deteriorating condition.

Section 5

As the critical care team continues to manage the patient’s complex condition, a new development emerges. Despite the initiation of high-frequency oscillatory ventilation (HFOV) and continuous renal replacement therapy (CRRT), the patient’s hemodynamic status further deteriorates. The blood pressure plummets to 80/50 mmHg, and the heart rate spikes to 128 bpm, raising concerns about septic shock. A repeat set of blood cultures is drawn, and a broad-spectrum antibiotic regimen is adjusted to include coverage for multidrug-resistant organisms, given the patient's history of tuberculosis and the high risk of nosocomial infections.

In parallel, a new diagnostic challenge presents itself as the patient begins to exhibit neurological changes. The patient becomes increasingly lethargic and difficult to arouse. A stat head CT is ordered, revealing no acute intracranial hemorrhage but some signs of cerebral edema. The neurocritical care team is engaged to assess the potential for central nervous system involvement due to hypoxemia or potential infection. The patient's Glasgow Coma Scale score drops to 9, necessitating close monitoring and potentially further neuroprotective strategies.

Meanwhile, the hematology team continues to address the disseminated intravascular coagulation (DIC). Despite transfusion efforts, the patient’s lab results show a drop in platelet count to 40,000/mm³ and an increase in D-dimer levels, reflecting ongoing consumptive coagulopathy. This necessitates further transfusions and the consideration of adjunctive therapies such as recombinant factor VIIa in consultation with the hematology specialists. As the patient’s clinical landscape becomes increasingly precarious, the team is challenged to integrate these evolving findings into a cohesive treatment strategy, balancing the risks of further interventions against the urgent need to stabilize the patient's rapidly changing condition.